Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

Similar articles for PubMed (Select 24656175)

1.

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.

Bonaparte M, Dweik B, Feroldi E, Meric C, Bouckenooghe A, Hildreth S, Hu B, Yoksan S, Boaz M.

BMC Infect Dis. 2014 Mar 21;14:156. doi: 10.1186/1471-2334-14-156.

2.

Evaluation of antiviral activity of essential oil of Trachyspermum Ammi against Japanese encephalitis virus.

Roy S, Chaurvedi P, Chowdhary A.

Pharmacognosy Res. 2015 Jul-Sep;7(3):263-7. doi: 10.4103/0974-8490.157977.

3.

Trend of Japanese encephalitis in Uttar Pradesh, India from 2011 to 2013.

Jain P, Singh AK, Khan DN, Pandey M, Kumar R, Garg R, Jain A.

Epidemiol Infect. 2015 Jun 26:1-8. [Epub ahead of print]

PMID:
26112391
4.

A Case Report of Japanese Encephalitis Focusing on MR Findings.

Lee HH, Huang LK, Hu CJ, Chen YT, Wu D.

Acta Neurol Taiwan. 2014 Dec;23(4):134-7.

PMID:
26082418
5.

Characterization of Japanese encephalitis virus (JEV) genotype III clinical isolates in northeast India.

Khan SA, Borah J, Chowdhury P, Dutta P, Mahanta J.

Trans R Soc Trop Med Hyg. 2015 Jun 14. pii: trv045. [Epub ahead of print]

PMID:
26073435
6.

Bilateral isolated basal ganglia bleed: An atypical presentation of Japanese encephalitis.

Mahale R, Mehta A, Rangasetty S.

Neurol India. 2015 May-Jun;63(3):456-7. doi: 10.4103/0028-3886.158269. No abstract available.

7.

In vitro Growth, Pathogenicity, and Serological Characteristics of the Japanese Encephalitis Virus Genotype V Muar strain.

Tajima S, Yagasaki K, Kotaki A, Tomikawa T, Nakayama E, Moi ML, Lim CK, Saijo M, Kurane I, Takasaki T.

J Gen Virol. 2015 Jun 5. pii: vir.0.000213. doi: 10.1099/vir.0.000213. [Epub ahead of print]

PMID:
26048886
8.
9.
10.

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.

Paulke-Korinek M, Kollaritsch H, Kundi M, Zwazl I, Seidl-Friedrich C, Jelinek T.

Vaccine. 2015 Jul 9;33(30):3600-4. doi: 10.1016/j.vaccine.2015.05.037. Epub 2015 May 30.

PMID:
26036947
11.

[The biological characteristic of the collection strains of viruses from the subgroup of Japanese encephalitis].

Loginova NV, Deryabin PG, Vashkova VV.

Vopr Virusol. 2015;60(1):17-20. Russian.

PMID:
26021067
12.

[Detection of serum antibodies against Japanese encephalitis virus in bats in Hainan and Guangdong Provinces of China].

Jiang L, Chen S, Zheng X, Ma S, Zhou J, Zhang Q, Li X, Xiong Y, Zhong X, Wang Z, Chen Q.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 May;35(5):720-3. Chinese.

13.

Short-Term Immunogenicity and Safety of an Accelerated Pre-Exposure Prophylaxis Regimen With Japanese Encephalitis Vaccine in Combination With a Rabies Vaccine: A Phase III, Multicenter, Observer-Blind Study.

Jelinek T, Burchard GD, Dieckmann S, B├╝hler S, Paulke-Korinek M, Nothdurft HD, Reisinger E, Ahmed K, Bosse D, Meyer S, Costantini M, Pellegrini M.

J Travel Med. 2015 May 22. doi: 10.1111/jtm.12210. [Epub ahead of print]

PMID:
25997707
14.

A novel immunochromatographic test applied to a serological survey of Japanese encephalitis virus on pig farms in Korea.

Cha GW, Lee EJ, Lim EJ, Sin KS, Park WW, Jeon DY, Han MG, Lee WJ, Choi WY, Jeong YE.

PLoS One. 2015 May 20;10(5):e0127313. doi: 10.1371/journal.pone.0127313. eCollection 2015.

15.

Identification and genome characterization of genotype B and genotype C bovine parainfluenza type 3 viruses isolated in the United States.

Neill JD, Ridpath JF, Valayudhan BT.

BMC Vet Res. 2015 May 15;11:112. doi: 10.1186/s12917-015-0431-8.

16.

Efficient production of Tymovirus like particles displaying immunodominant epitopes of Japanese Encephalitis Virus envelope protein.

Shahana PV, Das D, Gontu A, Chandran D, Maithal K.

Protein Expr Purif. 2015 Sep;113:35-43. doi: 10.1016/j.pep.2015.03.017. Epub 2015 May 7.

PMID:
25959459
17.

Japanese encephalitis associated acute encephalitis syndrome cases in West Bengal, India: A sero-molecular evaluation in relation to clinico-pathological spectrum.

Sarkar A, Datta S, Pathak BK, Mukhopadhyay SK, Chatterjee S.

J Med Virol. 2015 Aug;87(8):1258-67. doi: 10.1002/jmv.24165. Epub 2015 May 4.

PMID:
25939919
18.

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.

Wang SY, Cheng XH, Li JX, Li XY, Zhu FC, Liu P.

Hum Vaccin Immunother. 2015 Jun 3;11(6):1418-25. doi: 10.1080/21645515.2015.1011996.

PMID:
25915588
19.

Genotype-specific neutralization determinant in envelope protein: implications for the improvement of Japanese Encephalitis vaccine.

Ye Q, Xu YP, Zhang Y, Li XF, Wang HJ, Liu ZY, Li SH, Liu L, Zhao H, Nian QG, Deng YQ, Qin E, Qin CF.

J Gen Virol. 2015 Apr 23. pii: vir.0.000160. doi: 10.1099/vir.0.000160. [Epub ahead of print]

PMID:
25908779
20.

Monoclonal Antibodies Against NS2B of Japanese Encephalitis Virus.

Dong Q, Xu Q, Ruan X, Huang S, Cao S.

Monoclon Antib Immunodiagn Immunother. 2015 Apr;34(2):96-100. doi: 10.1089/mab.2014.0057.

PMID:
25897607
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk